Body Central (Nasdaq: BODY) reported earnings on Mar. 8. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Body Central beat slightly on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded significantly and GAAP earnings per share grew significantly.

Gross margins dropped, operating margins grew, net margins improved.

Revenue details
Body Central chalked up revenue of $80.7 million. The five analysts polled by S&P Capital IQ anticipated sales of $79.7 million on the same basis. GAAP reported sales were 20% higher than the prior-year quarter's $67.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.38. The five earnings estimates compiled by S&P Capital IQ predicted $0.37 per share. GAAP EPS of $0.38 for Q4 were 124% higher than the prior-year quarter's $0.17 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 34.7%, 210 basis points worse than the prior-year quarter. Operating margin was 12.2%, 320 basis points better than the prior-year quarter. Net margin was 7.6%, 350 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $86.2 million. On the bottom line, the average EPS estimate is $0.39.

Next year's average estimate for revenue is $354.3 million. The average EPS estimate is $1.49.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 26 members out of 28 rating the stock outperform, and two members rating it underperform. Among five CAPS All-Star picks (recommendations by the highest-ranked CAPS members), four give Body Central a green thumbs-up, and one gives it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Body Central is buy, with an average price target of $29.20.

While many retailers continue to struggle in these tough economic time, a select few are changing the face of the business, and reaping outsized rewards. Is Body Central the right stock for you? Read "The Death of Wal-Mart: The Real Cash Kings Changing the Face of Retail" and decide. Click here for instant access to this free report.